Moderna has expanded its phase 2/3 Covid-19 vaccine trial to include adolescents between the ages of 12 and 18 to gauge its vaccine's safety and efficacy on kids.
Brown talks special session, COVID-19 vaccine
KEZI
Moving forward, the state should expect future cuts to our vaccine allotment, Brown said.
